4//SEC Filing
Oosthuizen Johannes Jacobus 4
Accession 0001127602-24-014263
CIK 0000310158other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 4:01 PM ET
Size
8.6 KB
Accession
0001127602-24-014263
Insider Transaction Report
Form 4
Oosthuizen Johannes Jacobus
President, U.S. Market
Transactions
- Exercise/Conversion
Common Stock
2024-05-04$127.51/sh+912$116,289→ 24,270.949 total - Exercise/Conversion
Restricted Stock Unit
2024-05-04−912→ 0 totalFrom: 2022-05-04Exp: 2024-05-04→ Common Stock (912 underlying) - Tax Payment
Common Stock
2024-05-04$127.51/sh−450$57,380→ 23,820.949 total
Footnotes (3)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001916310
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 4:01 PM ET
- Size
- 8.6 KB